Back to company

BORREGAARD BIOPLANT ApS: Financial statements 2023

CVR: 21500445

BORREGAARD BIOPLANT ApS (CVR 21500445) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 9,116,413 and a net result of DKK -753,841 compared with DKK -1,458,607 the year before. That is a decrease of 8.9% compared with the year before. Equity amounted to DKK 5,608,145. The solvency ratio was 57.7%. The company had 22 employees in the financial year.

Gross Profit
9,116,413 kr.
Profit/Loss
-753,841 kr.
Equity
5,608,145 kr.
Total Assets
9,727,442 kr.
Employees
22

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-9.1 mio.-754 t.5.6 mio.22
2022-10 mio.-1.5 mio.7.4 mio.21
2021-11.8 mio.900 t.9.8 mio.20
2020-11.5 mio.596 t.8.9 mio.19
2019-9.1 mio.211 t.8.3 mio.20

Official annual report

View the official annual report directly on the page with a Pro subscription.

Events in 2023

BORREGAARD BIOPLANT ApS: The 2022 annual report is outMay 4, 2023

BORREGAARD BIOPLANT ApS has published its annual report for 2022. Gross profit came to DKK 10,002,306, and the net result was DKK -1,458,607.

Martin Lemche joins BORREGAARD BIOPLANT ApS as directorJan 1, 2023

As of January 1, 2023, Martin Lemche is registered as director of BORREGAARD BIOPLANT ApS.

About BORREGAARD BIOPLANT ApS

BORREGAARD BIOPLANT ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 1999. The company is registered under the industry Ikke-specialiseret engroshandel. The management consists of Martin Lemche. The company is owned by Biobest Group NV. The company has 18 employees. In 2025, the company reported a gross profit of DKK 10,536,766 and a net result of DKK 491,045 compared with DKK 421,195 the year before. Equity amounted to DKK 5,520,385.